HIGHLIGHTS
- who: Akash Khandelwal from the The healthcare business of Merck KGaA, Darmstadt, Germany have published the research work: Translation of liver stage activity of M5717, a Plasmodium elongation factor 2 inhibitor: from bench to bedside, in the Journal: (JOURNAL)
- what: This approach has the potential to accelerate the search for new anti-malarials to reduce the number of healthy volunteers needed in a clinical study and decrease and refine the animal use in the preclinical phase. The model was derived from results obtained from the completed Phase 1 clinical trial .
- how: In both . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.